Gallbladder Adenocarcinoma clinical trials at UC Health
1 research study open to new patients
Study of Experimental PEGPH20 and Atezolizumab With Standard Care in Patients With Liver or Biliary (bile duct) System Cancer
“This study is for patients with cancers involving the liver or biliary system and will test investigational drugs PEGPH20 and Atezolizumab.”
open to eligible people ages 18 years and up
The study is being conducted to assess the safety and tolerability of (1) PEGPH20 in combination with CIS and GEM (PEGCISGEM), and (2) PEGPH20 in combination with CIS, GEM, and atezolizumab (PEGCISGEMATEZO) compared with (3) cisplatin and gemcitabine (CISGEM).
at UC Irvine UC Davis UCLA